CAS 960404-86-8

Dapagliflozin Hydroxy Impurity

CAS: 960404-86-8

Formel: C₂₁H₂₅ClO₇

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 424.8720

Ref: IN-DA01FO13

(2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-Ethoxybenzyl)Phenyl)-6-(Hydroxymethyl)Tetrahydro-2H-Pyran-2,3,4,5-Tetraol

CAS: 960404-86-8

(2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-Ethoxybenzyl)Phenyl)-6-(Hydroxymethyl)Tetrahydro-2H-Pyran-2,3,4,5-Tetraol

Reinheit: 98%

Molekulargewicht: 424.87g/mol

Ref: 54-OR1022985

Dapagliflozin impurity

CAS: 960404-86-8

Molekulargewicht: 424.87

Ref: 10-F986923

Dapagliflozin impurity

CAS: 960404-86-8

Dapagliflozin impurity is the enantiomer of Dapagliflozin, Dapagliflozin is a sodium glucose transporter 2 inhibitor.

Formel: C₂₁H₂₅ClO₇

Farbe und Form: Solid

Molekulargewicht: 424.87

Ref: TM-T10957

Dapagliflozin Impurity 81

CAS: 960404-86-8

Formel: C₂₁H₂₅ClO₇

Molekulargewicht: 424.87

Ref: 4Z-D-6289

Dapagliflozin Hydroxy Impurity

CAS: 960404-86-8

Formel: C₂₁H₂₅ClO₇

Molekulargewicht: 424.9

Ref: ST-EA-CP-D8007

Dapagliflozin hydroxy impurity

CAS: 960404-86-8

Dapagliflozin hydroxy impurity is an amorphous, solid oral pharmaceutical composition that is orally administered for the treatment of diabetes mellitus. Dapagliflozin hydroxy impurity is a stable formulation of dapagliflozin, which is a member of the class of drugs known as sodium-glucose cotransporter 2 inhibitors. Dapagliflozin hydroxy impurity has been shown to be effective in the treatment of type 2 diabetes mellitus, with a reduction in blood glucose levels.

Formel: C₂₁H₂₅ClO₇

Reinheit: Min. 95%

Molekulargewicht: 424.9 g/mol

Ref: 3D-KNB40486